查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947525

奈米機器人市場：依類型（奈米操縱器、奈米機器人系統）、應用類別（體內、體外/體外）、技術（磁驅動、生物混合推進）、應用（醫療、分子製造）和最終用戶劃分－全球預測至2036年

Nanorobotics Market by Type (Nano-manipulators, Nanorobotic Systems), Deployment (In-vivo, In-vitro/Ex-vivo), Technology (Magnetic Actuation, Biohybrid Propulsion), Application (Healthcare, Molecular Manufacturing), End-User- Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 288 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

全球奈米機器人市場預計將以14.2%的複合年增長率成長，從2026年的82.7億美元成長到2036年的約311.9億美元。

本報告對全球五大主要地區的奈米機器人市場進行了詳細分析，重點關注當前市場趨勢、市場規模、近期發展以及至2036年的預測。透過廣泛的二級和一級研究以及對市場現狀的深入分析，本報告對關鍵產業驅動因素、限制因素、機會和挑戰的影響進行了分析。

推動奈米機器人市場成長的關鍵因素包括全球對精準醫療日益增長的興趣以及自主分子系統的快速發展。此外，人工智慧驅動的奈米醫學的整合、對即時細胞級幹預需求的不斷增長以及先進奈米機器人平台的擴展，預計將為該市場中的企業創造巨大的成長機會。

市場區隔

目錄

第一章：引言

第二章：摘要整理

第三章：市場概覽

  • 市場動態
    • 驅動因素
    • 限制因素
    • 機遇
    • 挑戰
  • 市場趨勢

第四章 全球奈米機器人市場（依類型劃分）

  • 奈米操縱器
    • 原子力顯微鏡 (AFM)
    • 掃描穿隧顯微鏡（STMs）
    • 其他
  • 奈米機器人系統
    • 生物奈米機器人
    • 磁導奈米機器人
    • 機電奈米機器人
    • 其他
  • 軟體與控制系統

第五章 全球奈米機器人市場依應用領域劃分

  • 體內應用
    • 標靶藥物遞送
    • 外科手術
    • 診斷影像
    • 組織工程與修復
    • 其他體內應用
  • 體外/離體應用
    • 實驗室研究
    • 藥物發現
    • 診斷與檢測
    • 其他體外應用應用

第六章 全球奈米機器人市場（依技術劃分）

  • 磁力驅動
    • 電磁場系統
    • 永磁系統
    • 混合磁力系統
  • 生物混合/生物推進
    • 細胞推進
    • 生物馬達系統
    • 混合生物合成系統
  • 聲音/超音波推進
    • 超音波驅動
    • 聲流
    • 共振系統
  • 光驅動
    • 光子推進
    • 光遺傳控制
    • 電漿系統
  • 其他技術

第七章 全球奈米機器人市場（依應用領域劃分）

  • 醫療
    • 藥物輸送
    • 診斷與影​​像
    • 奈米外科手術與組織修復
    • 牙科應用
    • 其他醫療應用
  • 分子製造
  • 研發
  • 環境監測
  • 工業與電子

第八章 全球奈米機器人市場（依最終用戶劃分）

  • 醫院與臨床中心
  • 製藥與生技公司
  • 學術與研究機構
  • 醫療器材原始設備製造商 (OEM)
  • 工業製造商
  • 其他最終用戶

第九章 全球奈米機器人市場依地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 瑞士
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲和紐西蘭
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 智利
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作委員會國家
      • 沙烏地阿拉伯阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 其他海灣合作委員會成員國
    • 南非
    • 以色列
    • 埃及
    • 奈及利亞
    • 其他中東和非洲國家

第十章 競爭格局

  • 主要公司策略
  • 競爭對手概覽
    • 行業領導者
    • 市場差異化因素
    • 先行企業
    • 新興企業
  • 主要公司市佔率分析

第11章 企業簡介

  • JEOL Ltd.(Japan)
  • Thermo Fisher Scientific Inc.(US)
  • Bruker Corporation(Germany)
  • Hitachi High-Tech Corporation(Japan)
  • ZEISS Group(Germany)
  • Oxford Instruments(UK)
  • Imina Technologies(Switzerland)
  • SmarAct GmbH(Germany)
  • Stereotaxis, Inc.(US)
  • Ginkgo Bioworks(US)
  • EV Group(Austria)

第12章 附錄

簡介目錄
Product Code: MRHC - 1041780

Nanorobotics Market by Type (Nano-Manipulators, Nanorobotic Systems), Deployment (In-Vivo, In-Vitro/Ex-Vivo), Technology (Magnetic Actuation, Biohybrid Propulsion), Application (Healthcare, Molecular Manufacturing), End-User (Hospitals & Clinical Centers, Research Institutions, Pharmaceutical Companies), and Geography - Global Forecast to 2036

According to the research report titled, 'Nanorobotics Market by Type (Nano-Manipulators, Nanorobotic Systems), Deployment (In-Vivo, In-Vitro/Ex-Vivo), Technology (Magnetic Actuation, Biohybrid Propulsion), Application (Healthcare, Molecular Manufacturing), End-User (Hospitals & Clinical Centers, Research Institutions, Pharmaceutical Companies), and Geography - Global Forecast to 2036,' the global nanorobotics market is expected to reach approximately USD 31.19 billion by 2036 from USD 8.27 billion in 2026, at a CAGR of 14.2% during the forecast period (2026-2036).

The report provides an in-depth analysis of the global nanorobotics market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.

The major factors driving the growth of the nanorobotics market include the intensifying global focus on precision medicine and the rapid expansion of autonomous molecular systems. Additionally, the integration of AI-driven nanomedicine, increasing demand for real-time cellular-level intervention, and expansion of advanced nanorobotic platforms are expected to create significant growth opportunities for players operating in the nanorobotics market.

Market Segmentation

The nanorobotics market is segmented by type (nano-manipulators, nanorobotic systems), deployment (in-vivo, in-vitro/ex-vivo), technology (magnetic actuation, biohybrid propulsion), application (healthcare, molecular manufacturing), end-user (hospitals & clinical centers, research institutions, pharmaceutical companies), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Type

By type, the nanorobotic systems segment holds the largest market share in 2026, primarily attributed to their comprehensive functionality in supporting targeted drug delivery and in-vivo diagnostics. Nanorobotic systems provide integrated solutions for complex medical applications. However, the nano-manipulators segment is expected to grow at the fastest CAGR during the forecast period, driven by the increasing demand for precision molecular assembly and structural manipulation at the nanoscale. The ability to deliver integrated solutions with proven clinical validation makes advanced nano-manipulator platforms highly attractive for research and pharmaceutical applications.

Based on Deployment

By deployment, the in-vitro/ex-vivo segment holds the largest market share in 2026, owing to its widespread adoption in laboratory research environments and pharmaceutical development workflows. In-vitro systems provide controlled environments for nanorobotic experimentation. The in-vivo segment is expected to witness significant growth during the forecast period, driven by the increasing demand for minimally invasive therapeutic interventions and real-time diagnostic capabilities. Advanced in-vivo nanorobotics represent an emerging frontier with tremendous potential for precision medicine applications.

Based on Technology

By technology, the magnetic actuation segment holds the largest share of the overall market in 2026, due to its proven effectiveness in enabling precise control and navigation of nanorobotic systems. Magnetic actuation provides reliable, non-invasive control mechanisms for nanoscale devices. The biohybrid propulsion segment is expected to grow at a significant CAGR during the forecast period, driven by the increasing adoption of biological propulsion systems and hybrid nanorobotic architectures. Advanced technology integration continues to enhance the capabilities and performance of nanorobotic systems.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. In 2026, North America dominates the global nanorobotics market with the largest market share, primarily attributed to massive investments in healthcare innovation and the presence of leading research institutions and pharmaceutical companies in the United States and Canada. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by aggressive government funding and the rapid adoption of advanced nanotechnologies in China, India, and Japan. Europe, Latin America, and the Middle East & Africa represent emerging markets with growing research infrastructure and increasing adoption of nanorobotic technologies.

Key Players

The key players operating in the global nanorobotics market are Calando Pharmaceuticals, Genentech (Roche), Arrowhead Research Corporation, Luna Innovations, NanoHorizon, Altair Nanotechnologies, Harris & Harris Group, and various other regional and emerging nanotechnology and healthcare innovation companies, among others.

Key Questions Answered in the Report-

  • What is the current revenue generated by the nanorobotics market globally?
  • At what rate is the global nanorobotics market demand projected to grow for the next 7-10 years?
  • What are the historical market sizes and growth rates of the global nanorobotics market?
  • What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of type, deployment, technology, and application are expected to create major traction for the service providers in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global nanorobotics market?
  • Who are the major players in the global nanorobotics market? What are their specific product offerings in this market?
  • What are the recent strategic developments in the global nanorobotics market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Nanorobotics Market Assessment -- by Type

  • Nano-Manipulators
  • Nanorobotic Systems

Nanorobotics Market Assessment -- by Deployment

  • In-Vivo
  • In-Vitro/Ex-Vivo

Nanorobotics Market Assessment -- by Technology

  • Magnetic Actuation
  • Biohybrid Propulsion

Nanorobotics Market Assessment -- by Application

  • Healthcare
  • Molecular Manufacturing

Nanorobotics Market Assessment -- by End-User

  • Hospitals & Clinical Centers
  • Research Institutions
  • Pharmaceutical Companies

Nanorobotics Market Assessment -- by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Scope
  • 1.3. Research Methodology
  • 1.4. Assumptions & Limitations

2. Executive Summary

3. Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
    • 3.2.4. Challenges
  • 3.3. Market Trends

4. Global Nanorobotics Market, by Type

  • 4.1. Introduction
  • 4.2. Nano-manipulators
    • 4.2.1. Atomic Force Microscopes (AFM)
    • 4.2.2. Scanning Tunneling Microscopes (STM)
    • 4.2.3. Others
  • 4.3. Nanorobotic Systems
    • 4.3.1. Bio-nanorobots
    • 4.3.2. Magnetically Guided Nanorobots
    • 4.3.3. Electromechanical Nanobots
    • 4.3.4. Others
  • 4.4. Software & Control Systems

5. Global Nanorobotics Market, by Deployment

  • 5.1. Introduction
  • 5.2. In-vivo Deployment
    • 5.2.1. Targeted Drug Delivery
    • 5.2.2. Surgical Interventions
    • 5.2.3. Diagnostic Imaging
    • 5.2.4. Tissue Engineering & Repair
    • 5.2.5. Other In-vivo Applications
  • 5.3. In-vitro/Ex-vivo Deployment
    • 5.3.1. Laboratory Research
    • 5.3.2. Drug Discovery
    • 5.3.3. Diagnostics & Testing
    • 5.3.4. Other In-vitro Applications

6. Global Nanorobotics Market, by Technology

  • 6.1. Introduction
  • 6.2. Magnetic Actuation
    • 6.2.1. Electromagnetic Field Systems
    • 6.2.2. Permanent Magnet Systems
    • 6.2.3. Hybrid Magnetic Systems
  • 6.3. Biohybrid/Biological Propulsion
    • 6.3.1. Cell-based Propulsion
    • 6.3.2. Biological Motor Systems
    • 6.3.3. Hybrid Bio-synthetic Systems
  • 6.4. Acoustic/Ultrasound Propulsion
    • 6.4.1. Ultrasonic Actuation
    • 6.4.2. Acoustic Streaming
    • 6.4.3. Resonance-based Systems
  • 6.5. Optical/Light-driven Actuation
    • 6.5.1. Photonic Propulsion
    • 6.5.2. Optogenetic Control
    • 6.5.3. Plasmonic Systems
  • 6.6. Other Technologies

7. Global Nanorobotics Market, by Application

  • 7.1. Introduction
  • 7.2. Healthcare
    • 7.2.1. Drug Delivery
    • 7.2.2. Diagnostics & Imaging
    • 7.2.3. Nanosurgery & Tissue Repair
    • 7.2.4. Dental Applications
    • 7.2.5. Other Healthcare Applications
  • 7.3. Molecular Manufacturing
  • 7.4. Research & Development
  • 7.5. Environmental Monitoring
  • 7.6. Industrial & Electronics

8. Global Nanorobotics Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals & Clinical Centers
  • 8.3. Pharmaceutical & Biotechnology Companies
  • 8.4. Academic & Research Institutes
  • 8.5. Medical Device OEMs
  • 8.6. Industrial Manufacturers
  • 8.7. Other End-Users

9. Global Nanorobotics Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. U.K.
    • 9.3.3. France
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Switzerland
    • 9.3.7. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. South Korea
    • 9.4.5. Australia & New Zealand
    • 9.4.6. Rest of Asia-Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Argentina
    • 9.5.4. Chile
    • 9.5.5. Colombia
    • 9.5.6. Rest of Latin America
  • 9.6. Middle East & Africa
    • 9.6.1. GCC Countries
      • 9.6.1.1. Saudi Arabia
      • 9.6.1.2. UAE
      • 9.6.1.3. Qatar
      • 9.6.1.4. Rest of GCC
    • 9.6.2. South Africa
    • 9.6.3. Israel
    • 9.6.4. Egypt
    • 9.6.5. Nigeria
    • 9.6.6. Rest of Middle East & Africa

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. Key Player Strategies
  • 10.3. Competitive Dashboard
    • 10.3.1. Industry Leader
    • 10.3.2. Market Differentiators
    • 10.3.3. Vanguards
    • 10.3.4. Emerging Companies
  • 10.4. Market Share Analysis, By Key Player

11. Company Profiles

  • 11.1. JEOL Ltd. (Japan)
  • 11.2. Thermo Fisher Scientific Inc. (US)
  • 11.3. Bruker Corporation (Germany)
  • 11.4. Hitachi High-Tech Corporation (Japan)
  • 11.5. ZEISS Group (Germany)
  • 11.6. Oxford Instruments (UK)
  • 11.7. Imina Technologies (Switzerland)
  • 11.8. SmarAct GmbH (Germany)
  • 11.9. Stereotaxis, Inc. (US)
  • 11.10. Ginkgo Bioworks (US)
  • 11.11. EV Group (Austria)

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization